Cardiopulmonary Bypass System Market is expected to be valued at US$ 271 million by 2032 | FMI

The global Cardiopulmonary Bypass System Market is expected to be valued at US$ 271 million by 2032, up from US$ 192 million in 2022, with a CAGR of 3.2% over the forecast period. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis …

Blood Cancer Treatment Market is anticipated to be valued US$ 12,943.6 Million by 2032 | FMI Analyst

Global Blood Cancer Treatment Demand (Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma) is expected to be valued at US$ 5,489.3 million in 2022, rising at a 10.2% CAGR to US$ 12,943.6 million from 2022 to 2032. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents …

Cryoballoon Ablation System Market is likely to hold a valuation of US$ 1,888.7 Million by 2032 | FMI Analyst

The global Cryoballoon Ablation System Market is expected to be worth US$ 1,105.7 million in 2022, rising to US$ 1,888.7 million by 2032. During the forecast period, demand for cryoballoon ablation systems is expected to grow at a CAGR of 5%. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers …

Kaempferol Market is expected to be valued at US$ 5.79 billion by 2032 | FMI Analyst

The Kaempferol Market, which was valued at US$ 3.91 billion in 2022, is expected to grow at a CAGR of 4% during the forecast period, reaching US$ 5.79 billion by 2032. Kaempferol provides excellent benefits like reducing the risk of chronic diseases like cancer, strengthening anti-oxidant defense against free radicals, offering resistance against inflammation, modulating …

Aquaculture Therapeutics Market is anticipated to account for US$ 4190.3 Million by 2032 | FMI

The global Aquaculture Therapeutics Market is expected to reach US$ 4190.3 Million by 2032, up from US$ 1634.8 Million in 2022, at a CAGR of 9.9% during the forecast period. The increasing need for effective aquaculture treatment is expected to drive up demand for aquaculture therapeutics. Furthermore, the rising prevalence of bacterial illnesses among aquaculture …

Dental Services Market is expected to garner a market value of US$ 586943.9 million by 2032 | FMI

The global Dental Services Market is expected to be worth US$ 586943.9 Million in 2032, with the market expanding at a positive CAGR of 6.2% from 2022 to 2032. The dental services market is expected to reach US$ 342685.5 Million in 2022, driven by rising incidences of poor oral health and rising awareness of dental …

Arteriovenous Fistula Treatment Market is anticipated to account for US$ 1,381.1 Million by 2032 | FMI

The global Arteriovenous Fistula Treatment Market is expected to generate approximately US$ 1,381.1 million by 2032, up from US$ 731.6 million in 2022, at a CAGR of 5.9% during the forecast period. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on …

Vascular Endothelial Growth Factor Inhibitor Market is expected to reach US$ 33.5 Billion by 2032 | FMI Analyst

The global Vascular Endothelial Growth Factor Inhibitors Market is predicted to be worth US$ 22.7 billion by the end of 2022, and to increase at a CAGR of 4.0% to be worth US$ 33.5 billion by 2032. According to a recent analysis by Future Market Insights, biologics are dominating the market as pharmaceuticals, with a …

Dental Fluoride Varnish Market is expected to reach US$ 229.3 Million by 2032 | FMI

As per Future Market Insights’ latest industry analysis, the global market valuation for Dental Fluoride Varnish Market was around US$ 151.6 Million in the year 2021, and is expected to grow at a CAGR close to 3.9% over the forecast period and is estimated to have a market value of US$ 229.3 Million in 2032. …

IV Fluid Transfer Drugs Devices Market to expand at a 3.4% value CAGR by 2032 | FMI Analyst

The global IV Fluid Transfer Drugs Devices Market is expected to be worth US$ 6,480.2 million in 2022. Sales of IV fluid transfer drugs devices are expected to grow at a CAGR of 3.4% between 2022 and 2032, totaling US$ 9,319.3 million. With the latest insights and statistics from the biggest pharmaceutical and healthcare device …